Agoracom Blog Home

Author Archive

Peak $PKK.ca $PKKFF Hires Former People’s Bank of China Senior Manager as Special Advisor $ALY.ca $DELX.ca $MOS.ca $MOGO.ca CTZ.ca $TRAD.ca

Posted by AGORACOM-JC at 8:01 AM on Friday, November 6th, 2020
Peak Fintech Group (@PEAK_Fintech) | Twitter
  • Announced that it has hired former People’s Bank of China senior manager, Mr. Wenjun Wu, as a special advisor to assist the Company in various business development capacities and in preparing the Company’s Cubeler Lending Hub platform for China’s upcoming digital currency.
  • Mr. Wu is currently the CEO of Chengfangyun Digital Technology Ltd. (CDT), a Fintech company located in Suzhou that he created to provide products and services designed to help companies, banks and financial institutions conduct transactions in digital yuan.

Montreal, Quebec–(November 6, 2020) – Peak Positioning Technologies Inc. (CSE: PKK) (OTCQX: PKKFF) (“Peak” or the “Company”), an innovative Fintech service provider to the Chinese commercial lending sector, today announced that it has hired former People’s Bank of China senior manager, Mr. Wenjun Wu, as a special advisor to assist the Company in various business development capacities and in preparing the Company’s Cubeler Lending Hub platform for China’s upcoming digital currency.

Mr. Wu is currently the CEO of Chengfangyun Digital Technology Ltd. (CDT), a Fintech company located in Suzhou that he created to provide products and services designed to help companies, banks and financial institutions conduct transactions in digital yuan. Prior to founding CDT, Mr. Wu was a senior manager at the People’s Bank of China (PBOC), China’s Central Bank, where he worked in the Credit Information Centre and Cross-border RMB Settlement departments while also leading the R&D department of the Central Bank’s Nanjing branch. CDT is currently working closely with the PBOC to promote the use and adoption of the digital yuan in Suzhou.

“We’re very pleased and excited to have Mr. Wu join our team to help us get Lending Hub ready for the digital RMB,” commented Peak Group China CEO, Mr. Liang Qiu. “The digital RMB has been in the works for a few years now as the Central Bank has been pushing the whole country toward a cashless society. It is therefore very important for a company like Peak, considering the services we provide, to be at the forefront of this evolution. Having an opportunity to work with Mr. Wu and to benefit from his expertise and direct connection to the PBOC is priceless”.

About Peak Positioning Technologies Inc.:

Peak Positioning Technologies Inc. is the parent company of a group of innovative financial technology (Fintech) subsidiaries operating in China’s commercial lending industry. Peak’s subsidiaries use technology, analytics and artificial intelligence to create an ecosystem of lenders, borrowers and other participants in China’s commercial lending space where lending operations are conducted rapidly, safely, efficiently and with the utmost transparency. For more information: http://www.peakpositioning.com.

For more information, please contact:

CHF Capital Markets
Cathy Hume, CEO
416-868-1079 ext.: 251
[email protected]

Peak Positioning Technologies Inc.
Johnson Joseph, President and CEO
514-340-7775 ext.: 501
[email protected]

Twitter: @peakfintech
Facebook: @peakfintech
LinkedIn: Peak Positioning
YouTube: Peak Positioning


Forward-Looking Statements / Information:

This news release may include certain forward-looking information, including statements relating to business and operating strategies, plans and prospects for revenue growth, using words including “anticipate”, “believe”, “could”, “expect”, “intend”, “may”, “plan”, “potential”, “project”, “seek”, “should”, “will”, “would” and similar expressions, which are intended to identify a number of these forward-looking statements. Forward-looking information reflects current views with respect to current events and is not a guarantee of future performance and is subject to risks, uncertainties and assumptions. The Company undertakes no obligation to publicly update or review any forward-looking information contained in this news release, except as may be required by applicable laws, rules and regulations. Readers are urged to consider these factors carefully in evaluating any forward-looking information.

Binovi $VISN.ca $BNVIF Announces Additional Private Placement of up to $2 Million $EYPT $KALA $PTON

Posted by AGORACOM-JC at 7:08 PM on Thursday, November 5th, 2020
http://www.smallcapepicenter.com/binovi%20square.png
  • Further to the private placement that closed on October 6, 2020, the Company plans to complete an additional non-brokered private placement financing for gross proceeds of up to $2,000,000, expected to close the week of November 9, 2020
  • The Private Placement will consist of up to 15,686,275 units at $0.1275 per unit, subject to the approval of the TSXV Venture Exchange. Each unit will be comprised of one common share and one share purchase warrant.

Toronto, New York – November 5, 2020 – Binovi Technologies Corp., (Binovi) (TSXV:VISN ) | ( OTCQB:BNVIF), a leader in neuro-vision performance technology, announces that further to the private placement that closed on October 6, 2020, the Company plans to complete an additional non-brokered private placement financing (the “Private Placement”) for gross proceeds of up to $2,000,000, expected to close the week of November 9, 2020. The Private Placement will consist of up to 15,686,275 units at $0.1275 per unit, subject to the approval of the TSXV Venture Exchange. Each unit will be comprised of one common share and one share purchase warrant. Each warrant entitles the holder to acquire a further common share at a price of $0.40 per share for a period of 24 months, subject to an acceleration clause.

The Company intends to use the net proceeds from the Private Placement for general working capital. All securities to be issued pursuant to the Private Placement are subject to a four-month hold period under applicable securities laws in Canada.

AGORACOM Agreement

Further to its news release dated April 28, 2020, the Company announces, it will make its third issuance of shares under its online marketing and awareness program with Agora Internet Relations Corp. (“AGORACOM”). Pursuant to this third tranche, the Company will issue 104,308 common shares of the Company at a deemed price of $0.13 subject to a hold period expiring February 7, 2021. AGORACOM’s program includes a “CEO Verified” Discussion Forum. The forum serves as the Company’s primary social media platform to interact with both shareholders and the broader investment community in a fully moderated environment.

The Binovi HUB can be found at https://agoracom.com/ir/BinoviTechnologies

For additional information on the Company, please visit https://www.binovi.com/investor-reports/

About Binovi Technologies Corp.

Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 20 countries.

Terry Booth

Executive Chairman

Adam Cegielski

Founder | CEO

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

https://www.binovi.com/investor-reports/

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

VIDEO: Affinity Metals $AFF.ca Key Property Acquisition Adjacent to the $110M Melkior Resources – Kirkland Lake Gold Carscallen Project $TUD.ca $GTT.ca $AMK.ca $OSK.ca $RKR.ca $MKR.ca $SII.ca $KL

Posted by AGORACOM-JC at 6:20 PM on Thursday, November 5th, 2020
Affinity Metals Corp. Acquires Five New Mineral Properties

Affinity Metals (AFF:TSX-V) (34IA: FSE)  recently made two key property acquisitions. The Carscallen Extension adjoins the Kirkland Lake / Melkior $110 million Joint Venture and is on trend. Melkior’s Carscallen property has gained considerable attention in recent months since Kirkland Lake Gold first entered into negotiations. Melkior recently closed a strategic partnership with KL in an option deal worth up to $110 million. The confidence of a major producer entering into an agreement of this size is very promising and shows the potential of this newly discovered gold system. 

The Windfall North is along strike to the northeast from Osisko’s rapidly growing Windfall Lake deposit within the prolific Abitibi Greenstone Belt. Osisko’s Windfall Lake Project is reportedly one of the highest grade resource-stage gold projects in Canada and continues to grow as more discoveries are made. Osisko recently reported Windfall Lake indicated resources of 2.39 million tonnes at 9.1 g/t Au (1,206,000 oz. gold) and inferred resources of 10.61 million tonnes at 8.4 g/t. (3,938,000 oz. gold).  Osisko has defined the resource approximately 2000m on strike and 1500m depth, and continues to drill at an impressive pace.

Sit back and discover why Affinity offers multiple opportunities to take advantage of a growing bull market in metals.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster. 

Kontrol $KNR $KNR.ca $KNR.c $KNRLF Receives CSA Standards Approval for BioCloud Technology $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 1:54 PM on Thursday, November 5th, 2020
kontrol-logo

 Kontrol BioCloud® a Safe Space Technology™ –

  • Announced that it has received CSA standards approval for its BioCloud® technology
  • “This is another important milestone for Kontrol and represents the continuing advancement of the BioCloud® technology,” says Paul Ghezzi, CEO Kontrol
  • CSA regulations require manufacturers of products sold in Canada to receive CSA Standards approval for electrical safety

TORONTO, ON / ACCESSWIRE / November 5, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to announce that it has received CSA standards approval for its BioCloud® technology.

“This is another important milestone for Kontrol and represents the continuing advancement of the BioCloud® technology,” says Paul Ghezzi, CEO Kontrol. “CSA is a Canadian standard for safety and is also accepted in jurisdictions outside Canada. In addition to CSA we continue to work on other important regional certifications including UL and CE for the United States and European markets respectively.”

Field Certification was provided by ESAFE

CSA regulations require manufacturers of products sold in Canada to receive CSA Standards approval for electrical safety. The field evaluation process follows the CSA’s SPE-1000 standard, which has three mandatory and non-destructive tests. Upon successful inspection, ESAFE validates the equipment meets CSA’s SPE-1000 standards and labels it approved. ESAFE’s labels are recognized across Canada under the Standards Council of Canada accreditation program.

ESAFE is accredited by the Standards Council of Canada (SCC), as an Inspection Body (ISO 17020) and Certification Body (ISO 17065). As an accredited agency, ESAFE is authorized to approve and label equipment for electrical safety.

www.esafe.org

About Kontrol BioCloud®

BioCloud® is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud® has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others

BioCloud® is not a medical device and the Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at: www.sedar.com.

Image: https://www.accesswire.com/users/newswire/images//10252018KNR2.pngImage: https://www.accesswire.com/users/newswire/images//10252018KNR3.pngImage: https://www.accesswire.com/users/newswire/images//10252018KNR4.png

For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud® Analyzer are subject to the risk that the Kontrol BioCloud® Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

$HPQ.ca NANO on Track to Start of Gen1 Reactor in December $EFL.ca $EGT.ca $ENPH $PYR.ca

Posted by AGORACOM-JC at 1:38 PM on Thursday, November 5th, 2020

The company announced today that technology provider PyroGenesis Canada Inc. (TSX-V: PYR) has updated HPQ NANO on the following PUREVAP TM Nano Silicon Reactor (“NSiR ”) development program milestones :

  • Process and mechanical engineering designs for the Gen1 PUREVAP TM NSiR have been completed, on time and on budget;
  • Gen1 fabrication will start next week, project is on schedule for a December 2020 commissioning and start.

MONTREAL, Nov. 05, 2020 — Innovative silicon solutions provider HPQ Silicon Resources Inc. (“HPQ” or “the Company”) ( TSX-V: HPQ FWB: UGE Other OTC : URAGF ) through its wholly – owned subsidiary, HPQ Nano Silicon Powders inc (“HPQ NANO”), is pleased to announce today that technology provider PyroGenesis Canada Inc. (TSX-V: PYR) has updated HPQ NANO on the following PUREVAP TM Nano Silicon Reactor (“NSiR ”) development program milestones :

  • Process and mechanical engineering designs for the Gen1 PUREVAP TM NSiR have been completed, on time and on budget;
  • Gen1 fabrication will start next week, project is on schedule for a December 2020 commissioning and start.

The process engineering phase allowed the PyroGenesis technical team to run a series of computer simulations to ensure that the system works as planned. Satisfied with the result, the mechanical engineering work needed to start the build of the Gen1 PUREVAP TM NSiR was then completed.

Bernard Tourillon, President & CEO of HPQ Silicon and HPQ NANO stated “It is very nice to see all the pieces of the puzzle falling into place We are just starting to visualize the potential commercial applications of the PUREVAP TM processes we are developing in close partnership with PyroGenesis, and I must say that I really like what we are seeing. While we are very excited by HPQ NANO material blue sky potential in the silicon battery space , we are also thrilled by our material potential in other high value markets, as this is another way for HPQ to expand its product markets by diversifying which could potentially reduce risk .”

PUREVAP TM NSiR LOW COST SPHERICAL SI LICON MATERIALS: A GAME CHANGING LEAP

Despite strong research and massive investment in Silicon material for batteries , current manufacturing processes are simply not scalable or commercially viable.

PyroGenesis, with 20+ years of experience in manufacturing plasma atomized metal powders, bring this massive knowhow to the development of the PUREVAP TM NSiR a scalable plasma-based Nano-Atomization process. PUREVAP TM NSiR will allow the low-cost transformation of metallurgical Silicon into tailor-made spherical silicon powders and/or Silicon Nanowires that battery and Electric Vehicle (EV) manufacturers are looking for.

With its capability of producing tailor made spherical silicon materials within a wide size distribution ranges (from < 0.20 m up to 5 m), the PUREVAP TM NSiR represents a game changing leap forward in resolving the issues of commercial viability and scalability.

HPQ NANO will be uniquely positioned to offer a wide spectrum of the products needed to meet the anticipated massive emerging demands from battery and EV manufactures.

PUREVAP TM QRR AND NSIR PRODUCT RANGE OPENS UP OTHER HIGH VALUE NICHE MARKET

HPQ NANO will also be uniquely positioned to offer the hydrogen sector access to a low-cost nano silicon powders alternative that can be used to extract H 2 from water.

Having the ability to use the metallurgical silicon (3N – 4N Si) to be produced by HPQ PUREVAP TM “Quartz Reduction Reactors” (QRR as feedstock for the PUREVAP TM NSiR , HPQ NANO will be able to come to market with a range of High Purity Si powder products presently used by specialty manufacturers. This represent an immediately addressable market of 100,000+ tonnes per year for HPQ NANO products. This represents 3% of the entire Silicon market which CRU 1 estimates will grow 15% by 2025.

Tourillon added “ What is truly becoming exciting about HPQ NANO is the competitive advantage we have in the massive EV and battery space, as well as, the competitive advantages we are starting to build in silicon products that we will be able to produce for alternative silicon markets. 

OTHER CORPORATE NEWS

In accordance with the agreement between HPQ-Silicon and Agoracom entered into on July 15, 2018 for the term ending July 15, 2020, HPQ-Silicon board has approved the issuance of 37,171 common shares at a deemed price of $0.38 per share to pay $14,125 for services rendered during the period from April 16, 2020 ending July 15, 2020. Each share issued pursuant to the debt settlement will have a mandatory four (4) month and one (1) day holding period from the date of closing.

As of July 15, 2020, HPQ-Silicon entered into a new agreement with Agoracom for the term ending July 15, 2021. HPQ-Silicon board has approved the new agreement and has approved the issuance of 25,223 common shares at a deemed price of $0.56 per share to pay $14,125 for services rendered during the period from July 16, 2020 ending October 15, 2020 in accordance with the new agreement. Each share issued pursuant to the debt settlement will have a mandatory four (4) month and one (1) day holding period from the date of closing. These agreement and debt settlement are subject to the approval of the TSX Venture Exchange.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com .

About HPQ Silicon

HPQ Silicon Resources Inc. TSX-V: HPQ ) is a Canadian Innovative Silicon Solutions Provider.

Silicon (Si), also known as silicon metal, is one of today’s key strategic materials needed for the decarbonization of the economy and the Renewable Energy Revolution (“RER”).

Silicon is the most abundant element in earth’s crust but does not exist in its pure state and must be extracted from quartz (SiO 2 ) in what has historically been a capital and energy intensive process. That is why HPQ is building a portfolio of silicon–based products using innovative scalable processes. The target objective is to produce high value speciality Silicon products using technologies that will reduce energy consumption, GHG’s, and carbon footprint. .

Working with PyroGenesis Canada Inc. (TSX-V: PYR) , a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAP TM “Quartz Reduction Reactors” (QRR) , an innovative process (patent pending), which will permit the one step transformation of quartz (SiO 2 ) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential ;
    • HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);
  • Through its 100% owned subsidiary HPQ NANO Silicon Powders Inc, the PUREVAP TM Nano Silicon Reactor (NSiR , a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;
    • HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries ;
    • During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAP TM SiNR .

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;
    • The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries;
    • Develop the hydrogen generation potential of Silicon nanopowders for usage with the Gennao TM system;
    • Commercialize, exclusively in Canada, and non-exclusive in the U.S.A., the Gennao TM H2 system and the chemical powders required for the hydrolysis production of Hydrogen (“H2”).

This News Release is available on the company’s CEO Verified Discussion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

AGORACOM Small Cap 60: Else Nutrition $BABY.ca $BABYF Has $30M In Cash And A $2.7B Shareholder To Launch Plant Based Toddler Foods Worldwide $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 12:27 PM on Thursday, November 5th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Highlights

  • $CAD 30 million in cash
  • Launched 1st Commercial Product Into US Market
  • Available via Amazon.com
  • Backed By A $2.7 Billion Dollar Global Nutrition Company;
  • Distribution agreement with one of the largest and most well regarded national fresh, organic and specialty food distributors in North America
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • Executives & Advisors From Globally Renowned Companies & Institutions
  • Received key Clean Label Certifications for Toddler Nutrition Product
  • Received Key USDA Organic Certification

$NAM.ca Provides #PGM and #Lithium Exploration Update $LIX.ca $LI.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 9:05 AM on Thursday, November 5th, 2020
  • Chairman and CEO, Harry Barr stated, “In the last week we have delivered over 300 River Valley samples from our core storage facility to Geolabs in Sudbury from which we expect assay results returned in early December. The analytical packages used at the lab will test for rhodium, palladium, platinum, ruthenium and iridium. Additionally, our field team in Manitoba have collected over 80 rock samples to be sent to Saskatchewan Research Council laboratories from our Lithium One Project. A second phase of rock sampling and mapping begins this week.”

November 5, 2020 – Rockport, Canada – New Age Metals Inc. (NAM) (TSXV:NAM ) ; ( OTC:NMTLF ) ; ( FSE:P7J) (“NAM” or the “Company”) NAM is pleased to provide an update on exploration activities for the Company’s two green metal divisions.

Chairman and CEO, Harry Barr stated, “In the last week we have delivered over 300 River Valley samples from our core storage facility to Geolabs in Sudbury from which we expect assay results returned in early December. The analytical packages used at the lab will test for rhodium, palladium, platinum, ruthenium and iridium. Additionally, our field team in Manitoba have collected over 80 rock samples to be sent to Saskatchewan Research Council laboratories from our Lithium One Project. A second phase of rock sampling and mapping begins this week.”

Exploration Update


Click Image To View Full Size

On September 29 the Company announced its plans for the third phase of exploration and development work at the flagship River Valley Palladium Project which includes the initiation of a project wide rhodium evaluation program and the second round of environmental baseline work in 2020. Story Environmental have scheduled the delivery of a final report presenting their work for the end of January 2021. The stated objective of the rhodium evaluation program is to ultimately evaluate the feasibility of including rhodium as a payable metal as part of the River Valley Project’s payable metal suite , that includes palladium, platinum, gold, copper, and nickel. The work in the final quarter of 2020 will focus on assaying historical River Valley samples for rhodium and other metals. This work will require follow-up metallurgical test work to prove rhodium recoverability.


Click Image To View Full Size

The Company’s River Valley core storage facility holds core from over 700 holes (above)


Click Image To View Full Size

Pictured above are field crew members from the Twohearts foundation who collaborated with New Age consultants at our latest field program at Lithium One.


Click Image To View Full Size

Above is a new outcrop exposure of the Silverleaf pegmatite displaying spodumene-lepidolite mineralization and on the right are.

Additional Activities for Q4 2020

Additional activities planned for Q4 regarding River Valley include exploration targeting which will continue to focus on footwall mineralization, though at the Dana South Zone in addition to the Pine Zone-T3 target. The interior of the River Valley Intrusion will also be re-evaluated for the possibility of MT and gravity surveys to aid development of targeting models for reef-type PGM deposits.

Shares for Services

The Company has issued 226,000 common shares at a deemed value of $0.06 per share to Agora Internet Relations Corp. (“AGORACOM”) pursuant to the terms of the March 2020 agreement. The securities issued represent the third payment for services under the terms of the agreement and are subject to a four month plus one day hold period expiring March 5, 2021.

About NAM

New Age Metals is a junior mineral exploration and development company focused on the discovery, exploration and development of green metal projects in North America. The Company has two divisions; a Platinum Group Metals division and a Lithium/Rare Element division. The PGM division includes the 100% owned, multi-million-ounce, district scale River Valley Project, one of North America’s largest undeveloped Platinum Group Metals Projects, situated 100 km from Sudbury, Ontario. The Company has recently completed a Preliminary Economic Assessment on the project and is working towards Prefeasibility. In Alaska the Company owns 100% of the Genesis PGM-Cu-Ni Project in Alaska. The Lithium division is the largest mineral claim holder in the Winnipeg River Pegmatite Field, where the Company is exploring for hard rock lithium and various rare elements such as tantalum and rubidium. Our philosophy is to be a project generator with the objective of optioning our projects with major and junior mining companies through to production. The Company is actively seeking an option/ joint venture partner for its road-accessible Genesis PGM-Cu-Ni project in Alaska and for our Lithium division in Manitoba.

About the River Valley Palladium Project

The details of the updated Mineral Resource Estimate (MRE) and Preliminary Economic Assessment (PEA) were announced in the press release dated August 9, 2019 and are described on NAM’s website. The pit constrained Updated Mineral Resource Estimate formed the basis of the PEA . At a cut-off grade of 0.35 g/t PdEq, the Updated Mineral Resource Estimate contains 2.867 Moz PdEq in the Measured plus Indicated classifications and 1.059 Moz PdEq in the Inferred classification. The PEA is a preliminary report, but it demonstrates that there are potentially positive economics for a large-scale mining open pit operation, with 14 years of Palladium production. Refer to the NAM website (www.newagemetals.com) for details.

Opt-in List

If you have not done so already, we encourage you to sign up on our website ( www.newagemetals.com ) to receive our updated news.

Qualified Person

The contents contained herein that relate to Exploration Results or Mineral Resources is based on information compiled, reviewed or prepared by Dr. Bill Stone, P.Geo., a consulting geoscientist for New Age Metals. Dr. Stone is the Qualified Person as defined by National Instrument 43-101 and has reviewed and approved the technical content of this news release.

On behalf of the Board of Directors

Harry Barr”

Harry G. Barr

Chairman and CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forw ard-looking statements.

FansUnite Entertainment $FANS.ca $FUNFF Betting Platform Achieves Record Month With 433% Increase In Revenue And 713% Increase In Gross Margin Vs. October 2019 $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 7:18 AM on Thursday, November 5th, 2020
  • UK Sportsbook set company records with triple-digit growth in multiple areas, led by a 433% increase in overall revenue compared to October 2019 and a total Gross win of $602K CAD during the month
  • Much of the growth was attributed to the unveiling of McBookie’s live casino games and increased activity in sports betting which resulted in $7.3M in total betting volume being placed during the month

Vancouver, British Columbia and Dundee, Scotland–(November 5, 2020) – FansUnite Entertainment Inc. (CSE: FANS) (OTC Pink: FUNFF) (“FansUnite” or the “Company”), a technology company providing leading online gaming solutions, is pleased to announce that its wholly owned subsidiary McBookie Ltd (“McBookie”) closed out October with the highest increase in monthly revenue and gross margin in the company’s 10-year history.

The UK Sportsbook set company records with triple-digit growth in multiple areas, led by a 433% increase in overall revenue compared to October 2019 and a total Gross win of $602K CAD during the month. Much of the growth was attributed to the unveiling of McBookie’s live casino games and increased activity in sports betting which resulted in $7.3M in total betting volume being placed during the month.

Casino Segment

McBookie’s new Live Casino product, encompassing multiple tables and variations of blackjack, roulette and baccarat, all with live real dealers, garnered substantial interest from online bettors.

During the month:

  • Betting volume (“Turnover”) was $5.1M CAD, an increase of 460% as compared to October 2019.
  • Gross Win was $197K CAD an increase of 679% as compared to October 2019.

Sports Segment

McBookie added new features, including ‘bet builder’, which enables online bettors to fully customize and build their bets across any number of markets, and instantly receive a price on their desired wager. The user-friendly feature combined with a full slate of English soccer fixtures and the Scottish National Soccer Team’s presence in the prestigious UEFA European Championship qualifiers, helped propel the company to new financial heights.

During the month:

  • Betting volume (“Turnover”) was $2.2M CAD, an increase of 188% as compared to October 2019.
  • Gross Win was $405K CAD, an increase of 363% as compared to October 2019.

“Despite the global pandemic, McBookie had a record-breaking month of growth in October and demonstrated how seasoned operators can not only pivot their business during challenging times but still produce results that propel their business to new heights,” said Scott Burton, CEO of FansUnite Entertainment. “With sports now starting to come back and new products in their casino offering, we have full faith that McBookie will establish themselves as the preeminent online betting platform in Scotland and expand their footprint throughout the highly sought after UK gambling industry.”

“We are very encouraged with the continued growth of the McBookie platform and continue to add new features to provide our customers with innovative solutions that will create a unique experience for them,” said Paul Petrie, founder and Director of McBookie. “With Serbia playing against Scotland in the European Championship Soccer Qualifiers, the US Masters beginning in two weeks and the Scottish Cup Final coming up in the next few months, sports are very much back in business and should see an increase in betting volume on our platform.”

About FansUnite Entertainment Inc.

FansUnite is a global sports and entertainment company, focusing on technology related to regulated and lawful online gaming and other related products. FansUnite has produced a one of a kind complete iGaming platform, Chameleon Gaming Platform, with a sports and esports focus geared for the next generation of online bettors and casino players. The platform includes products for pre-match betting, in-play betting, daily fantasy, content and a certified RNG to produce casino style chance games. The platform operates multiple B2C brands and B2B software for the online gambling industry. FansUnite also looks to acquire technology platforms and assets with high-growth potential in new or developing markets.

For further information, please contact:

Prit Singh Investor Relations at FansUnite
[email protected]
(905) 510-7636

Scott Burton Chief Executive Officer of FansUnite
[email protected]

Darius Eghdami President of FansUnite
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

DISCLAIMER REGARDING FINANCIAL INFORMATION: The preliminary financial information set forth in this release has been prepared by management based on information currently available to the Company. Accordingly, such financial information may be subject to change. All financial information contained in this news release is qualified in its entirety with reference to the Company’s audited financial statements for the financial year ended December 31, 2020, which will be filed on SEDAR as required by applicable laws. While the Company does not expect there to be any material changes to the financial information presented in this news release, to the extent that it is inconsistent with the information contained in the Company’s audited financial statements for the financial year ended December 31, 2020, the financial information contained in this news release shall be deemed to be modified or superseded by the Company’s audited financial statements. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation for purposes of applicable securities laws.

FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute “forward-‎looking information” under Canadian securities legislation. Generally, forward-looking information can be ‎identified by the use of forward-looking terminology such as “believes,” “belief,” “expects,” “intends,” ‎‎”anticipates,” “potential,” “should,” “may,” “will,” “plans,” “continue” or similar expressions to be uncertain ‎and forward-looking. Forward-looking statements may include, without limitation, statements relating to ‎future outlook and anticipated events such as: the establishment of McBookie as a preeiminent online ‎betting platform; the expansion of McBookie throughout the UK gambling industry; the effect of upcoming ‎sporting events on betting volume on the McBookie platform; the ‎Company’s unique portfolio of assets; and discussion of future plans, projections, objectives, estimates ‎and forecasts and the timing related thereto. Forward-looking statements are based on the Company’s ‎estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the ‎actual results, level of activity, performance or achievements of FansUnite to be materially different from ‎those expressed or implied by such forward-looking statements or forward-looking information. Additional ‎information regarding the risks and uncertainties relating to the Company’s business are contained under ‎the heading “Risk Factors” in the Company’s Non-Offering Prospectus dated March 27, 2020 filed on its ‎issuer profile on SEDAR at www.sedar.com and risks related to global pandemics, including the novel ‎coronavirus (COVID-19) global health pandemic, and the spread of other viruses or pathogens and influence ‎of macroeconomic developments. Accordingly, readers should not place undue reliance on forward-looking ‎statements and forward-looking information. The forward-looking statements in this news release are made ‎as of the date of this release. FansUnite disclaims and does not undertake to update or revise any forward-‎looking statements or forward-looking information, whether as a result of new information, future events or ‎otherwise, except as required by applicable securities laws.‎

Hollister $HOLL.ca $HSTRF Provides Comment on Approval of Recreational Cannabis in Arizona $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM-JC at 10:58 PM on Wednesday, November 4th, 2020
https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1
  • Company comments on the successful passage of Proposition 207 – legalizing the cultivation, sale and consumption of recreational cannabis in the state of Arizona
  • “Seeing recreational Cannabis legalized in the state is an encouraging sign and is hopefully another step toward federal legalization. It should lead to increased tax revenue and job creation. The recreational cannabis market in Arizona could be valued at up to US $760 million by 2024…” Shared Jacob Cohen , Founder of Venom Extracts, Hollister’s 100% owned subsidiary based in Arizona .

VANCOUVER, BC , Nov. 4, 2020 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the ” Company “, ” Hollister Cannabis Co. ” or ” Hollister “) a diversified cannabis branding company with products in over 280 dispensaries throughout California , and over 80 dispensaries throughout Arizona provides comment on the successful passage of Proposition 207 – legalizing the cultivation, sale and consumption of recreational cannabis in the state of Arizona .

“Seeing recreational Cannabis legalized in the state is an encouraging sign and is hopefully another step toward federal legalization. It should lead to increased tax revenue and job creation. The recreational cannabis market in Arizona could be valued at up to US $760 million by 2024 1 , significantly expanding the total addressable market for Cannabis in the state. We look forward to making our product line available to both the medical and recreational end user.” Shared Jacob Cohen , Founder of Venom Extracts, Hollister’s 100% owned subsidiary based in Arizona .

Arizona Presence

Hollister , through its 100% owned subsidiary, Venom Extracts (” Venom “), is one of Arizona’spremier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products. With an experienced management team and unparalleled reputation for quality, Venom prides itself as a differentiated extraction company by producing legal cannabis products at a price point that allows retailers to generate higher profits. Focused on proprietary efficiencies, Venom is able to produce more product per square foot than its competition, maintaining lower costs and risks than a typical extraction company.

Website: www.venomextracts.com

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CAbirthplace of the “American Biker”.

Website www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 
Source:  Marijuana Business Daily

 View original content to download multimedia: http://www.prnewswire.com/news-releases/hollister-provides-comment-on-approval-of-recreational-cannabis-in-arizona-301166780.html

SOURCE Hollister Biosciences Inc.

How Cannabis-Based Therapeutics Could Help Fight #COVID Inflammation – SPONSOR: Innocan Pharma $INNO.ca $IN.ca $AXIM $LABS $CRDL.ca $TBP.ca

Posted by AGORACOM-JC at 5:51 PM on Wednesday, November 4th, 2020
Innocan-Blog
  • InnoCan Pharma and Tel Aviv University are collaborating to explore the potential for CBD-loaded exosomes (minute extracellular particles that mediate intracellular communication, including via innate and adaptive immune responses)
  • The group plans to use these loaded exosomes to target and facilitate recovery of COVID-19–damaged lung cells
  • From a broader perspective, the prospects for harnessing cannabinoids for immune modulation will be more thoroughly explored in a special issue of Cannabis and Cannabinoid Research

By: Liz Scherer

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

Plagued by false starts, a few dashed hopes, but with perhaps a glimmer of light on the horizon, the race to find an effective treatment for COVID-19 continues. At last count, more than 300 treatments and 200 vaccines were in preclinical or clinical development (not to mention the numerous existing agents that are being evaluated for repurposing).

There is also a renewed interest in cannabinoid therapeutics — in particular, the nonpsychoactive agent cannabidiol (CBD) and the prospect of its modulating inflammatory and other disease-associated clinical indices, including SARS-CoV-2–induced viral load, hyperinflammation, the cytokine storm, and acute respiratory distress syndrome (ARDS).

Long hobbled by regulatory, political, and financial barriers, CBD’s potential ability to knock back COVID-19–related inflammation might just open doors that have been closed for years to CBD researchers.

Why CBD and Why Now?

CBD and the resulting therapeutics have been plagued by a complicated association with recreational cannabis use. It’s been just 2 years since CBD-based therapeutics moved into mainstream medicine — the US Food and Drug Administration (FDA) approved Epidiolex oral solution for the treatment of Lennox-Gastaut syndrome and Dravet syndrome, and in August, the FDA approved it for tuberous sclerosis complex.

CBD’s mechanism of action has not been fully elucidated, but on the basis of its role in immune responses — well described in research spanning more than two decades — it’s not surprising that cannabinoid researchers have thrown their hats into the COVID-19 drug development ring.

The anti-inflammatory potential of CBD is substantial and appears to be related to the fact that it shares 20 protein targets common to inflammation-related pathways, Jenny Wilkerson, PhD, research assistant professor at the University of Florida School of Pharmacy, Gainesville, Florida, explained to Medscape Medical News.

Among the various trials that are currently recruiting or are underway is one that is slated for completion this fall. CANDIDATE (Cannabidiol for COVID-19 Patients With Mild-to-Moderate COVID-19) is a randomized, controlled, double-blind study led by Brazilian researchers at the University of Sao Paulo. The study, which began recruitment this past August, enrolled 100 patients, 50 in the active treatment group (who received capsulated CBD 300 mg daily for 14 days plus pharmacologic therapy [antipyretics] and clinical measures) and 50 who received placebo.

Read Full Article: https://www.medscape.com/viewarticle/940265#vp_3